132 related articles for article (PubMed ID: 34851199)
1. Development and validation of ultra performance liquid chromatography-tandem mass spectrometry method for the simultaneous estimation of dolutegravir, lamivudine and tenofovir in bulk and tablet dosage form.
Veerareddy V; Dodda S; Gangarapu K
Eur J Mass Spectrom (Chichester); 2021 Dec; 27(6):249-255. PubMed ID: 34851199
[TBL] [Abstract][Full Text] [Related]
2. Box-Behnken design aided optimization and validation of developed reverse phase HPLC analytical method for simultaneous quantification of dolutegravir sodium and lamivudine co-loaded in nano-liposomes.
Mutalik SP; Mullick P; Pandey A; Kulkarni SS; Mutalik S
J Sep Sci; 2021 Aug; 44(15):2917-2931. PubMed ID: 34076952
[TBL] [Abstract][Full Text] [Related]
3. A rapid method for the simultaneous determination of L-ascorbic acid and acetylsalicylic acid in aspirin C effervescent tablet by ultra performance liquid chromatography-tandem mass spectrometry.
Wabaidur SM; Alothman ZA; Khan MR
Spectrochim Acta A Mol Biomol Spectrosc; 2013 May; 108():20-5. PubMed ID: 23454710
[TBL] [Abstract][Full Text] [Related]
4. High-performance liquid chromatography-tandem mass spectrometry for simultaneous determination of raltegravir, dolutegravir and elvitegravir concentrations in human plasma and cerebrospinal fluid samples.
Tsuchiya K; Ohuchi M; Yamane N; Aikawa H; Gatanaga H; Oka S; Hamada A
Biomed Chromatogr; 2018 Feb; 32(2):. PubMed ID: 28762239
[TBL] [Abstract][Full Text] [Related]
5. Development and validation of a rapid ultra high performance liquid chromatography with tandem mass spectrometry method for the simultaneous determination of darunavir, ritonavir, and tenofovir in human plasma: Application to human pharmacokinetics.
Reddy AV; Jaafar J; Aris AB; Majid ZA; Umar K; Talib J; Madhavi G
J Sep Sci; 2015 Aug; 38(15):2580-7. PubMed ID: 25989063
[TBL] [Abstract][Full Text] [Related]
6. A simple stability indicating RP-HPLC-DAD method for concurrent analysis of Tenofovir Disoproxil Fumarate, Doravirine and Lamivudine in pure blend and their combined film coated tablets.
Godela R; Gummadi S
Ann Pharm Fr; 2021 Nov; 79(6):640-651. PubMed ID: 34019910
[TBL] [Abstract][Full Text] [Related]
7. Development and validation of an assay for the simultaneous determination of zidovudine, abacavir, emtricitabine, lamivudine, tenofovir and ribavirin in human plasma using liquid chromatography-tandem mass spectrometry.
Kromdijk W; Pereira SA; Rosing H; Mulder JW; Beijnen JH; Huitema AD
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Mar; 919-920():43-51. PubMed ID: 23411018
[TBL] [Abstract][Full Text] [Related]
8. Analytical Method Development and Validation for the Simultaneous Estimation of Abacavir and Lamivudine by Reversed-phase High-performance Liquid Chromatography in Bulk and Tablet Dosage Forms.
Raees Ahmad SA; Patil L; Mohammed Usman MR; Imran M; Akhtar R
Pharmacognosy Res; 2018; 10(1):92-97. PubMed ID: 29568194
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous determination of intracellular concentrations of tenofovir, emtricitabine, and dolutegravir in human brain microvascular endothelial cells using liquid chromatography-tandem mass spectrometry (LC-MS/MS).
Patel SH; Ismaiel OA; Mylott WR; Yuan M; Hauser KF; McRae M
Anal Chim Acta; 2019 May; 1056():79-87. PubMed ID: 30797464
[TBL] [Abstract][Full Text] [Related]
10. A sensitive HPLC-MS/MS method for the determination of dolutegravir in human plasma.
Bennetto-Hood C; Tabolt G; Savina P; Acosta EP
J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Jan; 945-946():225-32. PubMed ID: 24361860
[TBL] [Abstract][Full Text] [Related]
11. Development of a simple and rapid method to determine the unbound fraction of dolutegravir, raltegravir and darunavir in human plasma using ultrafiltration and LC-MS/MS.
Zheng Y; Lui G; Boujaafar S; Aboura R; Bouazza N; Foissac F; Treluyer JM; Benaboud S; Hirt D; Gana I
J Pharm Biomed Anal; 2021 Mar; 196():113923. PubMed ID: 33571728
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous quantification of tenofovir, emtricitabine, rilpivirine, elvitegravir and dolutegravir in mouse biological matrices by LC-MS/MS and its application to a pharmacokinetic study.
Prathipati PK; Mandal S; Destache CJ
J Pharm Biomed Anal; 2016 Sep; 129():473-481. PubMed ID: 27497648
[TBL] [Abstract][Full Text] [Related]
13. A simple alternative and improved HPLC method for the estimation of doravirine, lamivudine, and tenofovir disoproxil fumarate in solid oral dosage form.
Kokkirala TK; Kancherla P; Alegete P; Suryakala D
Biomed Chromatogr; 2021 Aug; 35(8):e5121. PubMed ID: 33760252
[TBL] [Abstract][Full Text] [Related]
14. Development and validation of an ultra-high performance liquid chromatography-tandem mass spectrometry method to quantify antiretroviral drug concentrations in human plasma for therapeutic monitoring.
West RE; Oberly PJ; Riddler SA; Nolin TD; Devanathan AS
J Pharm Biomed Anal; 2024 Mar; 240():115932. PubMed ID: 38198884
[TBL] [Abstract][Full Text] [Related]
15. A novel LC-MS/MS method for simultaneous quantification of tenofovir and lamivudine in human plasma and its application to a pharmacokinetic study.
Matta MK; Burugula L; Pilli NR; Inamadugu JK; J V L N SR
Biomed Chromatogr; 2012 Oct; 26(10):1202-9. PubMed ID: 22222724
[TBL] [Abstract][Full Text] [Related]
16. A sensitive ultra-performance liquid chromatography-tandem mass spectrometry method for the simultaneous quantification of assay and trace-level genotoxic tosylate analogs (methyl and ethyl) in empagliflozin and its tablet dosage forms.
Nakka S; Muchakayala SK; Manabolu Surya SB
Biomed Chromatogr; 2024 Jan; 38(1):e5755. PubMed ID: 37903616
[TBL] [Abstract][Full Text] [Related]
17. An eco- friendly, selective, and sensitive spectrofluorimetric method for the quantification of Dolutegravir in its bulk and tablet dosage form.
Alossaimi MA; El Gamal RM; Altharawi A; Abbas M
Spectrochim Acta A Mol Biomol Spectrosc; 2022 May; 273():121035. PubMed ID: 35193000
[TBL] [Abstract][Full Text] [Related]
18. Switching to fixed-dose bictegravir, emtricitabine, and tenofovir alafenamide from dolutegravir plus abacavir and lamivudine in virologically suppressed adults with HIV-1: 48 week results of a randomised, double-blind, multicentre, active-controlled, phase 3, non-inferiority trial.
Molina JM; Ward D; Brar I; Mills A; Stellbrink HJ; López-Cortés L; Ruane P; Podzamczer D; Brinson C; Custodio J; Liu H; Andreatta K; Martin H; Cheng A; Quirk E
Lancet HIV; 2018 Jul; 5(7):e357-e365. PubMed ID: 29925489
[TBL] [Abstract][Full Text] [Related]
19. Selective determination of antiretroviral agents tenofovir, emtricitabine, and lamivudine in human plasma by a LC-MS-MS method for a bioequivalence study in healthy Indian subjects.
Yadav M; Singhal P; Goswami S; Pande UC; Sanyal M; Shrivastav PS
J Chromatogr Sci; 2010 Oct; 48(9):704-13. PubMed ID: 20875231
[TBL] [Abstract][Full Text] [Related]
20. UPLC-MS/MS method for the simultaneous quantification of anti-HBV nucleos(t)ides analogs: Entecavir, lamivudine, telbivudine and tenofovir in plasma of HBV infected patients.
De Nicolò A; Simiele M; Pensi D; Boglione L; Allegra S; Di Perri G; D'Avolio A
J Pharm Biomed Anal; 2015 Oct; 114():127-32. PubMed ID: 26037161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
